Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

Intensity Therapeutics abstract to be webcast at ASCO

Intensity Therapeutics reports that data highlighting the safety and efficacy results from the company’s clinical trial of its lead product candidate, INT230-6, will be presented at...

| By Kelley Gipson

Rothberg’s Homodeus prepares COVID test

Connecticut serial entrepreneur Jonathan Rothberg says his Guilford bioscience company Homodeus has begun scaling up production of its inexpensive, at-home COVID-19 test and expects to have...

| By Kelley Gipson

FDA: Contacts for medical devices re COVID-19

In regard to COVID-19 and medical devices, the FDA has issued various publications, including: Questions about Emergency Use Authorizations Guidance re shortages Rnforcement policies re certain...

| By Kelley Gipson

The Winstanley perspective on commercial real estate

With his brother Carter, Adam Winstanley runs the Concord, Mass.-headquartered company his father David founded in 1973. Winstanley Enterprises also has offices in New Haven and...

| By Kelley Gipson

BioSig’s ViralClear to proceed with COVID-19 treatment

Westport medical technology company BioSig Technologies and its majority-owned subsidiary ViralClear Pharmaceuticals have received FDA approval to proceed with a proposed COVID-19 treatment. ViralClear can...

| By Kelley Gipson

Wiggin and Dana: complimentary virtual IP consultations

In response to the COVID-19 pandemic and ongoing social distancing requirements, Wiggin and Dana’s IP Practice group is providing complimentary virtual IP consultations through video and...

| By Kelley Gipson

Rallybio completes $145 million Series B financing

Rallybio has completed a $145 million Series B financing. Proceeds from the financing will be used to advance Rallybio’s current portfolio of product candidates and...

| By Kelley Gipson

UConn wins grants for genomics and ovarian cancer

Researchers at UConn Health and The Jackson Laboratory for Genomic Medicine are collaborating to develop a training program for the next generation of genomic scientists...

| By Kelley Gipson

Sema4 named ‘2020 Cool Vendor’ by Gartner

Sema4 has been named a 2020 Cool Vendor in Healthcare Technology by Gartner Inc., the leading research and advisory company. According to Gartner, “healthcare delivery...